RxDoctor Payments Data

Christina Felizardo, PA

Medical · Newtown, CTNPI 1205563418

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.2% of the total across 546 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $7,101, more than ten times the $622 reported in 2022. Among medical clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,928in general payments, 2019–2025

Across 546 payments — averaging $29.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • LEO Pharma Inc.$2K
  • Johnson & Johnson$2K
  • Arcutis Biotherapeutics, Inc.$1K
  • Sanofi$1K
  • Lilly USA, LLC$1K
  • plus $6K from 16 others

What the payments were for

  • Consulting fees$1,1647%
  • Food & beverage$14,37290%
  • Education$3922%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,928 in reported general payments places this provider in the 95th percentile of 592 medical providers in Connecticut.

See all medical providers in Connecticut

Medicare billing

Part B allowed, 2024
$23,875
Medicare patients
89
Services billed
323

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab14$190,728
Dupixent PenDupilumab33$144,837
JubliaEfinaconazole12$9,162
Ketoconazole121$1,620
Fluocinonide35$1,158
Metronidazole12$933
Ciclopirox36$922
Doxycycline Hyclate22$714
Clobetasol Propionate25$639
Triamcinolone Acetonide69$520
Mupirocin19$135
Hydrocortisone21$83

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia$263$9,16212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 592 medical providers in Connecticut.

Other medical in Newtown

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →